Skip to main content
Equibles

Nuveen, LLC

Position in REPL — Replimune Group, Inc.

CIK 1871926 CHARLOTTE, NC
Back to REPL Full portfolio

Position in REPL

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$7,500,189
+$7,059,442 QoQ
Shares Held
677,524
+1076.0% QoQ
Ownership
0.719%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 199 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Nuveen, LLC holds $4,966,990,470 across 286 Biotechnology names. REPL ranks #87 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 2,019,974 $1,259,534,587
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,081,685 $537,305,388
3 EXEL
Exelixis, Inc.
 3,276,984 $178,300,697
4 ALNY
Alnylam Pharmaceuticals, Inc.
 315,630 $95,014,096
5 TGTX
Tg Therapeutics, Inc.
 1,625,876 $89,325,625
6 RVMD
Revolution Medicines, Inc.
 475,231 $89,001,259
7 JAZZ
Jazz Pharmaceuticals plc
 365,405 $88,051,641
8 ROIV
Roivant Sciences Ltd.
 1,970,504 $69,736,134

All Filings in REPL

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,500,189 677,524
2026-03-31 $440,747 57,614
2025-12-31 $560,008 57,614
2025-09-30 $241,402 57,614
2025-06-30 $1,182,867 127,327
2025-03-31 $6,546,256 671,411